| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |